不同来源绿僵菌对油桐鹰尺蠖幼虫的致病力比较

油桐鹰尺蠖Biston suppressaria (Guenée) 是一种杂食性食叶害虫,近年来在速生桉树林分中大 面积发生,造成较大的损失。文中研究了不同来源金龟子绿僵菌Metarhizium anisopliae 菌株生长与产孢 特性及对油桐鹰尺蠖幼虫的致病力,旨在筛选出高效防治该虫的生物资源。试验结果表明：不同来源的 绿僵菌菌株间菌落生长速度和产孢量差异显著,MaZPTR-01 菌株15 d 的菌落直径为6.5 cm,显著较其它 菌株大;MaFZ-13 和MaZPTR-01 菌株培养15 d 产孢量最高,分别为1.33×108 孢子· cm-2 和1.28×108 孢 子· cm-2。致病力测定结果表明：不同菌株对油桐鹰尺蠖幼虫的致病力存在显著差异,其中接种MaFZ-13 和MaZPTR-01 菌株的幼虫校正死亡率、僵虫率均较其它菌株高,接种后15 d 幼虫校正死亡率分别达到 94.5%、92.7%,僵虫率分别为75%、61.7%;这2 个菌株的致死中时（LT50）显著比其它菌株短,分别为 4.34 和4.52 d。绿僵菌MaFZ-13 和MaZPTR-01 菌株对油桐鹰尺蠖幼虫的致病力强,且具有良好的生产性 状,可作为该虫的生物防治资源进一步开发应用。     

乳铁蛋白在动物防御系统中的作用

<正>乳铁蛋白(LF)最初在牛乳中发现,后来发现这种蛋白质也广泛地存在于猪、鼠、人及其它哺乳动物的唾液、泪液、支气管粘液、胆汁、胰液等外分泌液以及嗜中性粒细胞次级颗粒和血浆中。正常生理条件下LF在血浆中含量很低,而富含于各种外分泌液和嗜中性粒细胞的次级颗粒中。     

羊的同期发情技术

论述了羊的同期发情技术原理、供受体同期发情处理方法、供受体发情时间以及发情检测方法,提出了羊的同期发情技术的应用范畴.     

奶牛杂交群体及其遗传评估的模拟研究

为验证在奶牛杂交群体中将品种组成和杂合度作为协变量的遗传评估理论,为奶牛杂交模式选择和杂交群体遗传评估等实际问题提供理论依据,结合我国奶业现状,本研究模拟了在低产荷斯坦牛群引入法系蒙贝利亚牛、德系西门塔尔牛进行杂交,采用随机交配和三品种轮回杂交模式、群体世代重叠17年的繁育过程.群体杂合度在第7年后趋于平衡,轮回杂交模式的群体杂合度高于随机交配.经过杂交,原中低产荷斯坦牛群体在产奶性能、生长性能方面都有进展,轮回杂交提高幅度相对略高.此外,利用品种效应和杂合度效应剖分杂种优势,采用单性状和多性状动物模型对模拟群体进行遗传评估,效果基本一致,都可以很好地用于杂交群体的遗传评估.结果表明,对荷斯坦牛中低产群体进行杂交,可实现生产性能和效益的提高,回归模型可用于多元群体的遗传评估.     

采用PCR-SSCP技术分析蚯蚓粪便的微生物群落结构

通过SDS/蛋白酶的方法抽提蚯蚓粪便微生物总DNA,以总DNA为模板,采用通用引物分别成功扩增细菌16S rRNA基因的V4-V5可变区,真菌18S rRNA基因的V8-V9可变区,应用单链构象多态性技术（SSCP）分析了蚯蚓粪便中不同空间层次的微生物种群的多样性。结果表明,在粪便的不同空间层次上呈现出明显的空间分布多样性,并且与纯蚯蚓粪微生物种群的多样性有很大的差别。为进一步的蚯蚓粪生态学功能研究提供了有益的指导。     

硫酸新霉素可溶性粉在靶动物猪的安全性研究

为了客观评价硫酸新霉素可溶性粉对靶动物猪临床应用的安全性,将32头仔猪随机分为4组,每组8头,分别设1倍、3倍、5倍临床推荐剂量组和空白对照组,连续混饮硫酸新霉素可溶性粉15 d,通过检测各组受试猪的临床表现、血液常规指标、血清生化指标、尿液常规指标及病理学变化等评价其临床用药的安全性。结果:硫酸新霉素可溶性粉以5倍临床推荐剂量内应用于靶动物猪后,对其临床症状、体重、血常规、血生化及尿常规等指标没有显著影响,解剖学及病理组织学检查也未见任何病理变化,说明硫酸新霉素可溶性粉以1倍、3倍、5倍临床推荐剂量应用于靶动物猪是安全的。     

Cardiomyopathy in Dystrophin-Deficient Hypertrophic Feline Muscular Dystrophy

A colony of cats affected with hypertrophic feline muscular dystrophy was used to study the occurrence of cardiomyopathy associated with dystrophin deficiency. Affected male and female cats, obligate carrier females, and unaffected healthy littermates were followed from 12 weeks of age into adulthood. Thoracic radiography, 2-D echocardiography, and 2-D-derived M-mode echocardiography were performed at 3-month intervals until 12 months of age and regularly thereafter. From 9 months of age, all affected cats had larger hearts than normal and carrier animals. Left ventricular wall thickness in systole and in diastole and interventricular septal thickness in systole were greater in affected cats 12 months and older when compared with normal or heterozygous animals (P < .05). The myocardium of affected cats was diffusely hypoechoic and thickened. Multiple hyperechoic foci were in the myocardium and papillary musculature. Shortening fraction was normal in all cats. Changes seen in carrier females included enlargement and hyperechogenicity of the papillary musculature after the age of 2 years. Gross and light microscopic examination revealed left ventricular wall thickening with multiple foci of mineralization in 2 of 5 hearts from dystrophin-deficient cats. Although approximately 10% of the normal dystrophin amount was present in the skeletal muscle, dystrophin could not be detected in the myocardium. Early onset concentric myocardial hypertrophy was present in all adult cats. Lesions were mainly localized in the myocardium of the left ventricular free wall and interventricular septum, papillary musculature, and the endocardium. Clinical signs of heart failure developed only infrequently in cats with hypertrophic feline muscular dystrophy.     

Regulation of fibroblast growth factor 9 on the differentiation of goat intramuscular adipocytes

It has been found that fibroblast growth factor receptor (FGF-FGFR) signaling can regulate the expression of adipocyte differentiation genes. FGF9 is one of the members of FGFs that mainly binds receptors FGFR2 and FGFR3. FGF9 is highly expressed in the adipose tissue of humans and mice, but there are few reports on the role of FGF9 in goat intramuscular adipocyte differentiation. Therefore, this study explored the effect of FGF9 on adipocyte differentiation through cell culture, interference, and overexpression. The expression of receptors FGFR1–FGFR4 in adipocyte differentiation and their effects on differentiation were detected to screen receptor gene of FGF9. Finally, the interaction between FGF9 and the receptor was tested by cotransfection. Our results showed that FGF9 interacts with FGFR2 to inhibit goat intramuscular adipocyte differentiation by regulating peroxisome proliferator-activated receptor gamma (PPARγ) and preadipocyte factor 1 (Pref1), which is a data support for subsequent pathway research.